In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
All content for On Medical Grounds is the property of Medavera and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
Everything Leads Back to the ED: STIs, Diagnostics, and Public Education
On Medical Grounds
30 minutes
1 year ago
Everything Leads Back to the ED: STIs, Diagnostics, and Public Education
Today On Medical Grounds, we will be speaking with return guest Dr. Christopher Colbert, Emergency Medicine physician with the University of Illinois at Chicago, about sexually transmitted infections (STIs), diagnostics in the emergency department (ED), and healthcare disparities. Active in all forms of digital media, Dr. Colbert also shares his thoughts on having a digital presence as a physician, and the use of new forms of media for medical education. In his many roles at UIC, as an...
On Medical Grounds
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
